| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Sep―30 |
Effect of new coronavirus infection carried during pregnancy on pregnancy and infant development |
L. Tomracheva |
| 2 |
[GO] |
2025―Sep―27 |
On the dynamics of occupational morbidity indicators in the Samara region during the pandemia COVID-19 and post-pandemic period (2019-2023) |
S. Babanov, T. Azovskova, N. Lavrentieva, A. Babanov, M. Artemyeva |
| 3 |
[GO] |
2025―Aug―30 |
Rehabilitation as a required stage in the treatment of the consequences of COVID-19 |
K. Avdeeva, A. Shcherbinina, T. Petelina, A. Gorbachevsky |
| 4 |
[GO] |
2025―May―01 |
In the footsteps of COVID-19. The evolution of the virus |
D. Starkova, E. Borodulina |
| 5 |
[GO] |
2025―May―01 |
The relationship between COVID-19 and the onset of neurodegenerative disease: clinical case |
L. Mirzaeva, A. Lobzina, V. Goldobin, M. Yushko, M. Lalova, A. Zuev, K. Akhmedova |
| 6 |
[GO] |
2025―Mar―31 |
Types of effects of SARS-CoV-2 on the human body: from coagulopathy to cytokine storm |
K. Nikolaychuk, S. Yakovleva, E. Shrayner, P. Platonova, M. Novikova, A. Tumas, et al. (+6) E. Vergunova, D. Lukichev, D. Sergeev, A. Khavkin, E. Pokushalov, D. Kudlay |
| 7 |
[GO] |
2025―Feb―24 |
COVID-19, tuberculosis and community-acquired pneumonia: a combined lung lesion (clinical case) |
S. Zubakina, K. Zhilinskaya, E. Borodulina, E. Vdoushkina, E. Yakovleva, E. Povalyaev |
| 8 |
[GO] |
2025―Feb―24 |
Changes in biochemical and coagulological blood tests in patients with bronchial asthma who underwent COVID-19 |
R. Abdullaev, V. Shorokhova, O. Komissarova |
| 9 |
[GO] |
2024―Aug―24 |
Peripheral nervous system damage in coronavirus infection: research results |
N. Amosova, S. Kucherenko, V. Ratnikov, T. Alekseeva |
| 10 |
[GO] |
2024―Jul―31 |
Clinical features and effectiveness of treatment of patients with pulmonary tuberculosis who have had COVID-19 |
A. Zakharov, N. Chernykh, R. Amansakhedov, I. Stepanyan, V. Romanov, A. Ergeshov |
| 11 |
[GO] |
2024―Jul―31 |
Indicators of hemostasis and fibrinolysis systems and systemic inflammatory response in patients with newly diagnosed sarcoidosis after COVID-19 |
R. Abdullaev, V. Shorokhova, N. Makaryants, O. Komissarova |
| 12 |
[GO] |
2024―Jul―31 |
Clinical and laboratory features of the course of COVID-19-associated ischemic stroke with fatal outcome |
L. Chichanovskaya, O. Bakhareva, V. Kosolapova, M. Burova, O. Makarova |
| 13 |
[GO] |
2024―Jul―30 |
Correlations of systemic blood cytokines in patients with coronary heart disease and experienced COVID-19 |
V. Negrebetsky, N. Agarkov, D. Shmarova |
| 14 |
[GO] |
2024―Jul―30 |
A personalized approach to discharge and follow-up of patients with COVID-19 |
A. Samkov, O. Burgasova, M. Chesnokova, I. Tyurin |
| 15 |
[GO] |
2024―Jul―30 |
The state of the psychoemotional sphere and coping strategy in therapists during the pandemic of the novel coronavirus infection COVID-19 |
S. Babanov, N. Ostryakova, L. Strizhakov, M. Lysova, A. Agarkova, V. Lotkov |
| 16 |
[GO] |
2024―Jul―30 |
THROMBOTIC AND THROMBOEMBOLIC COMPLICATIONS OF A NEW CORONAVIRUS INFECTION COVID-19 A MEDICAL WORKER (A CLINICAL CASE WITH AN UNFAVORABLE OUTCOME) |
L. Strizhakov, S. Babanov, T. Azovskova, N. Lavrentyeva, R. Baraeva |
| 17 |
[GO] |
2024―Jul―09 |
Markov model in evaluating the efficiency of various COVID-19 treatment regimens |
E. Vdoushkina, E. Borodulina, E. Gladunova, L. Povalyaeva |
| 18 |
[GO] |
2024―Jul―09 |
Relationship of comorbidity to the severity of the course of the novel coronavirus infection in patients who have delivered in a District Clinical Hospital of Khanty-Mansiysk |
E. Chernaya, A. Kasparova, V. Yanin, E. Kutefa, E. Vasilkovskaya, L. Chegus, et al. (+2) S. Semenchenko, F. Hidirnebieva |
| 19 |
[GO] |
2024―Jul―05 |
A case of concomitant branching anomalies of the tracheobronchial tree in a female patient with COVID-19 |
M. Shteiner, Yu. Biktagirov, E. Korymasov, E. Krivoshchekov, A. Zhestkov, A. Makova |
| 20 |
[GO] |
2024―Jun―26 |
Comparative evaluation of endothelial dysfunction in carbohydrate imbalance in patients with and without COVID-19 |
N. Mukhamadzie Askarov, L. Khidirova, Z. Osmieva |
| 21 |
[GO] |
2024―Jun―21 |
Clinical and biochemical features of the course of COVID-19 in patients with arterial hypertension |
A. Mordyk, N. Bagisheva, M. Moiseeva, E. Antipova, V. Streltsova |
| 22 |
[GO] |
2024―Jun―21 |
Occupational burnout in physicians after the COVID-19 pandemic |
M. Khabibulina, O. Bazhenova, M. Shamilov |
| 23 |
[GO] |
2024―May―12 |
Effects of SARS-CoV-2 on the endocrine system |
O. Kruglova, I. Demko, E. Sobko, S. Geyl, Yu. Khramova, E. Mineeva |
| 24 |
[GO] |
2024―May―11 |
DEVELOPMENT AND CLINICAL VALIDATION OF A REAGENT KIT FOR SIMULTANEOUS DETECTION OF INFLUENZA A, B, INFLUENZA A H1pdm09 AND CORONAVIRUS SARS-CoV-2 |
M. Dmitryukova, M. Maltyzova, M. Senina, А. Gushin |
| 25 |
[GO] |
2024―May―11 |
The importance of monitoring viral activity and viral load of SARS-CoV-2 |
O. Burgasova, A. Samkov, V. Gushchin, I. Tyurin |
| 26 |
[GO] |
2024―Apr―28 |
Substance use among young people during the COVID-19 pandemic |
K. Amlaev, V. Mazharov, O. Kravchenko, V. Zafirova, D. Khubieva |
| 27 |
[GO] |
2024―Apr―25 |
A retrospective analysis of the causes of an adverse outcome in COVID-19 and HIV coinfection in the stage of secondary diseases |
Ya. Eremushkina, T. Kuskova, S. Potekaeva |
| 28 |
[GO] |
2024―Apr―25 |
Assessment of clinical data and the species composition of pathogens in the upper respiratory tract of patients with COVID-19 AND Determination of sensitivity to essential etiotropic drugs |
S. Dolinny, L. Kraeva, O. Burgasova, D. Ogarkova |
| 29 |
[GO] |
2024―Apr―25 |
The use of selenium-containing drugs in the prevention and treatment of complications in patients with COVID-19 |
D. Dedov, P. Poluboyarinov, A. Fedorov |
| 30 |
[GO] |
2024―Apr―22 |
The use of L-lysine aescinate in patients with novel coronavirus infection and acute cerebrovascular accident |
E. Tokareva, V. Gorbunov |
| 31 |
[GO] |
2024―Mar―05 |
Pathological anatomy of COVID-19 |
A. Redko, O. Bunga |
| 32 |
[GO] |
2024―Mar―05 |
Indicators of hemostasis and fibrinolysis systems, clinical blood count and C-reactive protein in patients with chronic obstructive pulmonary disease after SARS-CoV-2 infection |
R. Abdullaev, V. Shorokhova, N. Makaryants, O. Komissarova |
| 33 |
[GO] |
2024―Feb―29 |
HISTORY OF PATIENTS WITH NEW CORONAVIRUS INFECTION
AND PRETERM BIRTH |
Е. Chernaya, Е. Kutefa |
| 34 |
[GO] |
2022―Nov―25 |
Complications of severe COVID-19 (dinical case) |
S. Plastinina, A. Tulichev, E. Makarova, N. Lyubavina, N. Menkov, E. Konyukhova, et al. (+4) M. Chmuzh, A. Sidnev, D. Vasina, M. Kuzmina |
| 35 |
[GO] |
2022―Nov―25 |
Particular issues of bronchoscopy in patients with the novel coronavirus (COVID-19) infection |
M. Shteiner, Yu. Biktagirov, M. Bereslavsky, E. Korymasov, E. Krivoshchekov, A. Zhestkov |
| 36 |
[GO] |
2022―Nov―25 |
What we know about COVID-19 vaccination |
E. Mineeva, I. Demko, E. Sobko, K. Shadrina |
| 37 |
[GO] |
2022―Nov―25 |
A clinical case of a lesion of the central nervous system associated with a novel coronavirus infection COVID-19: problems of diagnosis and examination of the connection with the profession of a medical worker |
S. Babanov, T. Azovskova, N. Lavrentyeva |
| 38 |
[GO] |
2022―Nov―07 |
IMPACT OF THE COVID-19 PANDEMIC ON THE DEVELOPMENT OF DESYNCHRONOSIS IN MEDICAL STUDENTS AND ITS POSSIBLE CORRECTION |
I. Novitsky, T. Potupchik, A. Kupriyanov, T. Perevertov |
| 39 |
[GO] |
2022―Nov―07 |
COVID-19: pathogenetic aspects |
M. Akhmedova, O. Burgasova, I. Imamova, M. Maksudova |
| 40 |
[GO] |
2022―Aug―29 |
Chaga birch mushroom: anti-inflammatory, antioxidant, immunomodulatory, antiviral effects, the possibility of using the Russian drug BioChaga in patients with novel coronavirus infection (COVID-19) |
D. Dedov, O. Usolceva |
| 41 |
[GO] |
2022―Aug―02 |
Indicators of clinical and biochemical blood tests in patients with the extremely severe course of the novel coronavirus infection COVID-19 |
R.Yu. Abdullaev, O.G. Komissarova, M.M. Rybka, Yu.S. Berezovsky |
| 42 |
[GO] |
2022―Aug―02 |
Emotional burnout syndrome in healthcare workers during the COVID-19 pandemic |
S.A. Babanov, N.A. Ostryakova, L.A. Strizhakov, A.S. Agarkova, V. Lotkov |
| 43 |
[GO] |
2022―Jun―30 |
Intraoperative monitoring of laboratory parameters of age-related diseases, by using information systems during the novel coronavirus infection |
N. Zhukova, S. Rukavishnikova, U. Saginbaev, T. Akhmedov, A. Pushkin, S. Lenkin |
| 44 |
[GO] |
2022―Jun―30 |
The role of metformin in the treatment of elderly patients with type 2 diabetes mellitus and coronavirus infection |
O. Belousova, M. Chupakha, A. Rukavishnikov, S. Lenkin |
| 45 |
[GO] |
2022―May―31 |
Novel coronavirus infection (COVID-19): epidemiology, clinical characteristics of patients, risk of complications, prevention, use of selenium-containing drugs |
D. Dedov |
| 46 |
[GO] |
2022―May―31 |
Features of the course of COVID-19 and HIV co-infection |
Ja. Eremushkina, T. Kuskova, P. Filippov, S. Potekaeva, O. Ogienko |
| 47 |
[GO] |
2022―Apr―26 |
Features of computed tomography in diagnostics COVID-19 |
V. Ryazanov, V. Kutsenko, S. Sadykova, S. Menshikova, P. Seliverstov |
| 48 |
[GO] |
2022―Apr―26 |
Novel coronavirus infection: selenium, selenium-containing drugs, prevention of complications |
D. Dedov |
| 49 |
[GO] |
2022―Mar―09 |
DYNAMICS OF REGIONAL MORTALITY RATES IN RUSSIA IN 2016-2019 COMPARED TO THOSE IN 2020: THE «CONTRIBUTION» OF COVID-19 |
I. Samorodskaya |
| 50 |
[GO] |
2022―Mar―09 |
HEMOPTYSIS AS A MANIFESTATION OF MALLORY-WEISS SYNDROME IN A PATIENT WITH NEW CORONAVIRUS INFECTION COVID-19 |
M. Steiner, Yu. Biktagirov, A. Zhestkov, E. Korymasov, E. Krivoshchekov |
| 51 |
[GO] |
2022―Mar―09 |
INDIVIDUAL REACTIONS FROM THE PERIPHERAL NERVOUS SYSTEM IN THE CONDITIONS OF THE COVID-19 PANDEMIC |
A. Raevskaya, A. Deryabin, I. Vyshlova, S. Karpov |
| 52 |
[GO] |
2022―Feb―24 |
New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements |
D. Dedov |
| 53 |
[GO] |
2022―Feb―16 |
Significance of indicators of intestinal permeability, the state of the microbiota in the development of gastroenterological manifestations in the treatment of patients with a new coronavirus infection (COVID-19) |
A. Ratnikova, V. Grinevich, V. Ratnikov, K. Kozlov, V. Gorelov, Yu. Kravchuk |
| 54 |
[GO] |
2022―Feb―16 |
A clinical case of inflammatory cardiomyopathy due to experienced subacute viral myocarditis associated with the new coronavirus infection COVID-19 of occupational genesis |
S. Babanov, T. Azovskaya, N. Vakurova, N. Lavrentyeva, R. Baraeva, A. Ryabov, et al. (+2) A. Agarkova, N. Ostryakova |
| 55 |
[GO] |
2021―Dec―27 |
COVID-19 and pneumocystis pneumonia in a patient with HIV infection |
L. Povalyaeva, A. Sukhanova, E. Yakovleva, B. Borodulin, O. Ushmodina, L. Peshkova |
| 56 |
[GO] |
2021―Dec―27 |
The incidence of respiratory diseases during the pandemic of the new coronavirus infection COVID-19 in the Russian Federation |
A. Shastin, T. Bushueva, V. Gazimova, T. Obukhova, A. Zhdanov |
| 57 |
[GO] |
2021―Dec―27 |
Time course of changes in the list of drugs for the treatment of COVID-19 in the temporary guidelines |
Ya. Shirobokov, E. Gladunova, E. Borodulina, D. Kudlaf, L. Povalyaeva |
| 58 |
[GO] |
2021―Dec―24 |
The features of a humoral response in patients with COVID-19 |
L. Generalova, O. Burgasova, V. Gushchin, L. Kolobukhina, V. Bakalin, V. Tetova, et al. (+2) M. Odnoralov, E. Generalov |
| 59 |
[GO] |
2021―Dec―24 |
Telemonitoring of the health status in pregnant women during the novel coronavirus (COVID-19) infection pandemic |
N. Ankudinov, A. Sitnikov, F. Sitnikov, S. Martirosyan |
| 60 |
[GO] |
2021―Aug―18 |
The first experience in the surgical treatment of pulmonary tuberculosis in patients who have experienced COVID-19 |
A. Ergeshov, M. Bagirov, E. Krasnikova, L. Lepekha |
| 61 |
[GO] |
2021―Aug―18 |
Organizational and management solutions to control the spread of COVID-19 |
A. Trunin, I. Chudinov, V. Lebedeva, D. Aleshina, A. Ilina, Ya. Shirobokov, A. Melerzanov |
| 62 |
[GO] |
2021―Jul―21 |
Impact of thymalin on the values of cells, humoral immunity and the life quality in elderly patients with COVID-19 |
V. Khavinson, B. Kuznik, S. Rukavishnikova, S. Trofimova, N. Linkova, T. Akhmedov, V. Bashuk |
| 63 |
[GO] |
2021―Jul―21 |
Components of sociomedical rehabilitation and adaptation in older patients under COVID-19 conditions |
T. Alenskaya |
| 64 |
[GO] |
2021―Jul―21 |
Impact of coronavirus infection on cognitive functions in elderly patients |
T. Potupchik, L. Evert, Yu. Kostyuchenko |
| 65 |
[GO] |
2021―Jun―08 |
Markers of the hemostatic and fibrinolytic systems in patients with surgical tuberculosis who have experienced COVID-19 |
R. Abdullaev, O. Komissarova, E. Krasnikova, M. Bagirov, A. Ergeshov |
| 66 |
[GO] |
2021―Jun―08 |
Multifaceted coronavirus |
O. Kravtsova, G. Bagirova |
| 67 |
[GO] |
2021―May―17 |
CALL CENTERS AS INFORMATION AND PSYCHOLOGICAL ASSISTANCE TO THE POPULATION DURING THE SPREAD OF THE NOVEL CORONAVIRUS INFECTION (COVID-19) |
A. Benyan, E. Borodulina, A. Kalinkin, A. Sutyagin, K. Zhilinskaya |
| 68 |
[GO] |
2021―Apr―12 |
COVID-19 in healthcare workers: problems of examining the association of the disease with occupation |
S. Babanov, V. Lotkov, N. Ostryakova, T. Kiryushina, A. Agarkova |
| 69 |
[GO] |
2021―Apr―12 |
A case of successful treatment of a child with multisystem inflammatory syndrome against the background of a COVID-19 infection |
M. Ermachenko, A. Popelkov, Yu. Zemin, R. Ivanov, E. Radionova, O. Klimova, et al. (+12) O. Gavazyuk, M. Suprun, S. Saltykova, N. Mkrtchyan, S. Guskov, M. Simbirtseva, R. Khakimov, D. Mamasev, S. Butakov, P. Popelkova, T. Penkova, E. Kozlova |
| 70 |
[GO] |
2021―Feb―16 |
Features of the course of cardiovascular pathology and type 2 diabetes mellitus in patients with COVID-19 |
E. Polozova, V. Skvortsov, L. Chegodaeva, N. Kurkina, T. Prokhorova, N.B.A. Al-Zakhar, N. Nefedov |
| 71 |
[GO] |
2020―Dec―30 |
Management of asthenic patients after COVID-19 |
M. Zhestikova, M. Gerasimenko, S. Kan, V. Minenkov, T. Aikina |
| 72 |
[GO] |
2020―Dec―04 |
Effect of tocilizumab and thymalin on systemic inflammation in patients with COVID-19 |
B. Kuznik, V. Khavinson, S. Lukyanov, K. Shapovalov, Yu. Smolyakov, P. Tereshkov, et al. (+4) Yu. Shapovalov, V. Konnov, D. Zaitsev, E. Magen |
| 73 |
[GO] |
2020―Dec―04 |
The timing of referral and the severity of condition in patients with lung damage and suspected novel coronavirus infection on admission to hospital during the beginning of the pandemic |
E. Vdoushkina, E. Borodulina, L. Povalyaeva, A. Sukhanova, K. Zhilinskaya, A. Sutyagin |
| 74 |
[GO] |
2020―Sep―23 |
Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions |
D. Kudlay, Ya. Shirobokov, E. Gladunova, E. Borodulina |
| 75 |
[GO] |
2020―Sep―23 |
HEMATOLOGICAL INDICATORS AS PREDICTORS OF THE OUTCOME OF A NEW CORONAVIRUS INFECTION COVID-19 PATIENTS OF DIFFERENT AGE GROUPS |
S. Rukavishnikova, T. Akhmedov, A. Pushkin, U. Saginbaev |
| 76 |
[GO] |
2020―Sep―23 |
The use of Thymaline to correct immune status deviations in COVID-19 (rationale for the use of drug and clinical case) |
S. Lukyanov, B. Kuznik, V. Khavinson, K. Shapovalov, Yu. Smolyakov, P. Tereshkov, et al. (+3) Yu. Shapovalov, V. Konnov, E. Magen |
| 77 |
[GO] |
2020―Jul―13 |
The coronavirus pandemic: the life of elderly people under lockdown |
Alehina A.V., Siljutina M.V., Chernov A.V., Testova S.G., Taranina O.N. |
| 78 |
[GO] |
2020―Jun―18 |
Laboratory indicators of coronАvirus infection COVID-19 |
Abdullaev R.Ju., Komissarova O.G. |
| 79 |
[GO] |
2020―Jun―18 |
Organizational and clinical problems of outpatient COVID-19 diagnostics |
Samorodskaja I.V., Larina V.N., Nazimkin K.E., Larin V.G. |
| 80 |
[GO] |
2020―Jun―18 |
Medications for COVID-19 prevention and therapeutic approaches during early-stage infection |
Andzhaparidze A., Burgasova O.A. |
| 81 |
[GO] |
2020―May―15 |
The problems of COVID-19 diagnosis and treatment: a clinical case example |
Samorodskaja I.V., Kljuchnikov I.V. |
| 82 |
[GO] |
2020―May―15 |
THE ROLE OF CORONAVIRUS INFECTION IN THE DEVELOPMENT OF DECOMPENSATION OF CARDIOVASCULAR DISEASES. THERAPY OPTIONS |
Zueva I.B., Plaksin O.Ju. |
| 83 |
[GO] |
2020―Mar―16 |
PREVENTION AND TREATMENT OF CORONAVIRUS INFECTION |
Isakov V. |
